跳转至内容
Merck
CN

SML2304

盐酸氯氮平N-氧化物

≥98% (HPLC), powder, muscarinic DREADD activator

别名:

盐酸氯氮平N-氧化物, 8-氯-11-(4-甲基-1-哌嗪基)-5H-二苯并[b,e](1,4)二氮杂N-氧化物, 盐酸盐

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

经验公式(希尔记法):
C18H19ClN4O · xHCl
化学文摘社编号:
分子量:
342.82 (free base basis)
UNSPSC Code:
12352119
NACRES:
NA.77
Assay:
≥98% (HPLC)
Form:
powder
Storage condition:
desiccated
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


产品名称

盐酸氯氮平N-氧化物, ≥98% (HPLC), Water soluble Clozapine N-oxide

biological source

synthetic

assay

≥98% (HPLC)

form

powder

storage condition

desiccated

solubility

DMSO: 40 mg/mL, water: 40 mg/mL

shipped in

ambient

storage temp.

2-8°C

SMILES string

ClC1=CC2=C(NC(C=CC=C3)=C3C(N4CC[N+]([O-])(C)CC4)=N2)C=C1.[xHCl]

InChI

1S/C18H19ClN4O/c1-23(24)10-8-22(9-11-23)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3

InChI key

OGUCZBIQSYYWEF-UHFFFAOYSA-N

General description

氯氮平n -氧化物盐酸盐是氯氮平n -氧化物(CNO)的一种水溶性形式(Sigma cat# C0832)。CNO是非典型抗精神病药物氯氮平的一种惰性代谢产物。CNO是设计药物特异激活的化学遗传设计受体(DREADD)中工程Gq蛋白偶联受体(GPCR)配体。DREADD的典型应用是测试,增强神经元和非神经元细胞的神经元放电和激活Gq信号。

通过使用细胞类型特异性启动子驱动DREADD表达可以实现对细胞群体的选择性靶向,并通过重组系统进一步控制该启动子的表达。DREADD对内源性配体的亲和力较低,其组成活性较低,但可能被CNO等合成化合物激活。

低nM浓度的CNO激活了DREADD系统,并调动了细胞内钙。当小鼠和大鼠按推荐剂量(一般为0.1-3 mg/kg)给药时,CNO在药理学和行为学上似乎是惰性的。CNO通常通过注射给药,但也可以混合到食物或饮用水中。

Other Notes

这不是药用级别的产品。


pictograms

Skull and crossbones

signalword

Danger

hcodes

Hazard Classifications

Acute Tox. 3 Oral - STOT SE 3

target_organs

Central nervous system

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Susan M Ferguson et al.
The Journal of neuroscience : the official journal of the Society for Neuroscience, 33(28), 11668-11676 (2013-07-12)
The dorsal striatum has been implicated in reward-based decision making, but the role played by specific striatal circuits in these processes is essentially unknown. Using cell phenotype-specific viral vectors to express engineered G-protein-coupled DREADD (designer receptors exclusively activated by designer
Blaine N Armbruster et al.
Proceedings of the National Academy of Sciences of the United States of America, 104(12), 5163-5168 (2007-03-16)
We evolved muscarinic receptors in yeast to generate a family of G protein-coupled receptors (GPCRs) that are activated solely by a pharmacologically inert drug-like and bioavailable compound (clozapine-N-oxide). Subsequent screening in human cell lines facilitated the creation of a family
Michael J Krashes et al.
The Journal of clinical investigation, 121(4), 1424-1428 (2011-03-03)
Several different neuronal populations are involved in regulating energy homeostasis. Among these, agouti-related protein (AgRP) neurons are thought to promote feeding and weight gain; however, the evidence supporting this view is incomplete. Using designer receptors exclusively activated by designer drugs



全球贸易项目编号

货号GTIN
SML2304-5MG04061838662064